Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07547462
NA

Optimizing Early Cesarean Scar Healing

Sponsor: Hamad Medical Corporation

View on ClinicalTrials.gov

Summary

This randomized controlled trial compares hydrophilic methacrylate gel versus beta-sitosterol ointment for early cesarean section scar healing. Adult women who underwent cesarean delivery were randomly assigned to receive either hydrophilic methacrylate gel (n=58) or beta-sitosterol ointment (n=59). Scar outcomes were assessed by trained nurses blinded to treatment allocation and by patients at two time points approximately 12 days apart. The primary outcome was scar redness measured by the Vancouver Scar Scale. Secondary outcomes included pigmentation, pliability, scar height, and patient-reported measures including pain, itching, satisfaction, and treatment recommendation.

Official title: Optimizing Early Cesarean Scar Healing: A Randomized Controlled Trial of Hydrophilic Methacrylate Gel Versus Beta-Sitosterol Ointment

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

117

Start Date

2023-12-15

Completion Date

2024-11-01

Last Updated

2026-04-23

Healthy Volunteers

No

Interventions

DRUG

Beta-Sitosterol Ointment

Topical ointment containing beta-sitosterol applied to cesarean section incision site

DRUG

Hydrophilic Methacrylate Gel

Hydrophilic methacrylate-based hydrogel applied to cesarean section incision site

Locations (1)

Al Wakra Hospital

Doha, Qatar